| [68Ga]Ga-NOTA-T4 | | Phase 3 Clinical | Renji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine | Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Head and Neck Neoplasms; Liver Neoplasms; Lung Neoplasms; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 詳細 |
| [18F]F-RESCA-T4 | | Phase 3 Clinical | Renji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine | Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Head and Neck Neoplasms; Liver Neoplasms; Lung Neoplasms; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 詳細 |
| [18F]F-RESCA-RT4 | | Phase 3 Clinical | Renji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine | Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Head and Neck Neoplasms; Liver Neoplasms; Lung Neoplasms; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 詳細 |
| [68Ga]Ga-NOTA-RT4 | | Phase 3 Clinical | Renji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine | Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Head and Neck Neoplasms; Liver Neoplasms; Lung Neoplasms; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 詳細 |
| JSKN-016 | JSKN-016; JSKN016 | Phase 3 Clinical | Jiangsu Alphamab Biopharmaceuticals Co Ltd | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastroesophageal Junction Neoplasms; Metastatic breast cancer; Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms | 詳細 |
| SHR-A1921 | SHR-A1921; SHRA1921; SHR-1921 | Phase 3 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd | Brain metastases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Metastatic breast cancer; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Salivary Gland Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| ESG-401 | STI-3258; OQY-3258; ESG-401 | Phase 3 Clinical | Shanghai Escugen Biotechnology Co Ltd | Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms | 詳細 |
| FDA018 Antibody Drug Conjugate | FDA018-ADC; FDA-018-ADC; F0024 | Phase 3 Clinical | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd | Breast Neoplasms; Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| GQ-1010 | PBI-410; GQ1010; BHV1510; BHV-1510; GQ-1010 | Phase 2 Clinical | GeneQuantum Healthcare (Suzhou) Co Ltd | Carcinoma; Carcinoma, Non-Small-Cell Lung; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy (The University Of Texas MD Anderson Cancer Center) | | Phase 2 Clinical | The University Of Texas MD Anderson Cancer Center | Carcinoma; Colorectal Neoplasms; Neoplasm Metastasis | 詳細 |
| ASP-2998 | ASP-2998; ASP2998 | Phase 2 Clinical | Astellas Pharma Global Development Inc | | 詳細 |
| Trop2-ADC (Sun Yat-Sen Memorial Hospital Of Sun Yat-Sen University) | | Phase 2 Clinical | Sun Yat-Sen Memorial Hospital Of Sun Yat-Sen University | Triple Negative Breast Neoplasms | 詳細 |
| VBC-103 | AVZO-103; VAC-103; VBC-103; VBC103 | Phase 2 Clinical | VelaVigo Cayman Ltd | Carcinoma; Carcinoma, Transitional Cell; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| IBI-3014 | IBI3014; IBI-3014 | Phase 2 Clinical | | | 詳細 |
| Trop2 CAR-NK cell therapy(Henan Provincial Cancer Hospital) | | Phase 2 Clinical | Henan Provincial Cancer Hospital | Carcinoma, Non-Small-Cell Lung | 詳細 |
| MDX-2001 | MDX2001; MDX-2001 | Phase 2 Clinical | ModeX Therapeutics Inc | Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Kidney Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Thyroid Neoplasms; Uterine Cervical Neoplasms | 詳細 |
| OBI-902 | OBI-902 | Phase 2 Clinical | Obi Pharma Inc | | 詳細 |
| OBI-992 | BSI-992; BSI992; R-992; OBI-992 | Phase 2 Clinical | Biosion Inc | Carcinoma, Non-Small-Cell Lung; Small Cell Lung Carcinoma; Solid tumours; Stomach Neoplasms | 詳細 |
| HS-20105 | HS-20105; HS20105 | Phase 2 Clinical | Hansoh BioMedical R&D Company | | 詳細 |
| IBI130 | IBI130; IBI-130 | Phase 2 Clinical | | Neoplasm Metastasis; Solid tumours | 詳細 |
| Anti TROP2 antibody drug conjugate ADC(Fudan University) | | Phase 2 Clinical | Fudan University | Triple Negative Breast Neoplasms | 詳細 |
| XYD-9668-198 | XYD-9668-198 | Phase 2 Clinical | Kunshan Xinyunda Biotechnology Co Ltd | | 詳細 |
| 9MW-2921 | 9MW2921; 9MW-2921 | Phase 2 Clinical | Mabwell (Shanghai) Bioscience Co Ltd | | 詳細 |
| MHB036C | MHB-036C | Phase 2 Clinical | Minghui Pharmaceutical Pty Ltd | Breast Neoplasms; Lung Neoplasms; Neoplasms; Solid tumours | 詳細 |
| BAT-8008 | BAT-8008; BAT8008 | Phase 2 Clinical | Bio-Thera Solutions Ltd | Carcinoma, Non-Small-Cell Lung; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| DB-1305 | DB1305; BNT325; BNT-325; DB-1305 | Phase 2 Clinical | Duality Biologics (Suzhou) Co Ltd | | 詳細 |
| BIO-106 | BIO-106 | Phase 2 Clinical | Hangzhou Baikai Biopharmaceutical Co Ltd | | 詳細 |
| BL-M02D1 | | Phase 2 Clinical | Baili-Bio (Chengdu) Pharmaceutical Co Ltd, Sichuan Baili Pharmaceutical Co Ltd | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Digestive System Neoplasms; Gastrointestinal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| LCB-84 | LCB-84 | Phase 2 Clinical | Legochem Biosciences Inc | | 詳細 |
| DAC-002 | JS-108; DAC-002/JS108; DAC-002 | Phase 1 Clinical | Hangzhou Dac Biotech Company Ltd | Small Cell Lung Carcinoma; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| AK-146-D-1 | AK146D1; AK-146-D1 | Phase 1 Clinical | | | 詳細 |
| KH-815 | KH815; KH-815 | Phase 1 Clinical | Chengdu Kanghong Biotechnologies Co Ltd | | 詳細 |
| IBI-3007 | IBI3007; IBI-3007 | Phase 1 Clinical | | | 詳細 |
| BL-M19D1 | BL-M08D1; BL-M19D1 | Phase 1 Clinical | Sichuan Biokin Pharmaceutical Co Ltd | Lymphatic Diseases; Lymphoma; Neoplasm Metastasis; Solid tumours | 詳細 |
| HS-20124 | HS-20124; HS20124 | Phase 1 Clinical | Hansoh BioMedical R&D Company | | 詳細 |
| IBR-822 | IBR822; IBR-822 | Phase 1 Clinical | Imbioray (Hangzhou) Biomedicine Co Ltd | | 詳細 |
| DXC-1002 | DXC1002; DXC-1002 | Phase 1 Clinical | Hangzhou Dac Biotech Company Ltd | | 詳細 |
| DS-001 | DS001; DS-001 | Phase 1 Clinical | Dartsbio Pharmaceuticals Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | | 詳細 |
| FZ-AD004 | F0040; FZ-AD004 | Phase 1 Clinical | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd | | 詳細 |
| U87 CAR-T cell therapy(Unicar-Therapy Bio-Medicine Technology) | U-87 | Phase 1 Clinical | Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd | Head and Neck Neoplasms; Lung Neoplasms; Nasopharyngeal Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| BCG-011 | DM-001; BCG-011 | Phase 1 Clinical | | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| MT-302 | MT-302 | Phase 1 Clinical | Myeloid Therapeutics Inc | Breast Neoplasms; Carcinoma; Colonic Neoplasms; Lung Neoplasms | 詳細 |
| 99mTc-radiolabeled TROP2 targeting nanobody (Shanghai Novamab Biopharmaceuticals/Chinese Academy of Sciences/Peking Union Medical College Hospital/Peking University) | | Clinical | Peking University | Breast Neoplasms; Triple Negative Breast Neoplasms | 詳細 |
| 99mTc-MY6349 | 99mTc-MY-6349 | Clinical | Peking Union Medical College Hospital | | 詳細 |
| 68Ga-THP-Trop2 VHH | | Clinical | The First Affiliated Hospital Of Xiamen University | | 詳細 |
| [18F]F-RESCA-EPCD6 | | Clinical | Renji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine | Carcinoma, Non-Small-Cell Lung | 詳細 |
| [68Ga]Ga-NOTA-EPCD6 | | Clinical | Renji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine | Carcinoma, Non-Small-Cell Lung | 詳細 |
| 89Zr-DFO-hSR7 | | Clinical | Beijing Cancer Hospital | Triple Negative Breast Neoplasms | 詳細 |
| TROP-2-targeted anti-CD74 siRNA (Immunomedics) | | | Immunomedics Inc | | 詳細 |
| 68Ga-TROP2 | | | Fudan University | | 詳細 |